Causative Role of PDLIM2 Epigenetic Repression in Lung Cancer and Therapeutic Resistance

Nature Communications - United Kingdom
doi 10.1038/s41467-019-13331-x
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Role of RLIP76 in Doxorubicin Resistance in Lung Cancer (Review)

International Journal of Oncology
Cancer ResearchOncology
2009English

Apoptosis Evasion: The Role of Survival Pathways in Prostate Cancer Progression and Therapeutic Resistance

Journal of Cellular Biochemistry
BiochemistryCell BiologyMolecular Biology
2005English

New Strategies in Lung Cancer: Epigenetic Therapy for Non-Small Cell Lung Cancer

Clinical Cancer Research
Cancer ResearchOncology
2014English

Sodium-Coupled Monocarboxylate Transporter Is a Target of Epigenetic Repression in Cervical Cancer

International Journal of Oncology
Cancer ResearchOncology
2019English

Drug Resistance in Lung Cancer

Lung Cancer: Targets and Therapy
Oncology
2010English

Epigenetic Inactivation of the RUNX3 Gene in Lung Cancer

Oncology Reports
MedicineCancer ResearchOncology
2006English

Molecular Pathways and Therapeutic Targets in Lung Cancer

Oncotarget
Oncology
2014English

Corrigendum: Metabolism and Epigenetic Interplay in Cancer: Regulation and Putative Therapeutic Targets

Frontiers in Genetics
GeneticsMolecular Medicine
2019English

Novel Third-Generation EGFR Tyrosine Kinase Inhibitors and Strategies to Overcome Therapeutic Resistance in Lung Cancer

Cancer Research
Cancer ResearchOncology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy